|
| 34813500 | Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. | J Clin Invest | 2022 |
| 35388616 | Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations. | Aging Cell | 2022 |
| 35307406 | Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans. | EBioMedicine | 2022 |
| 35047668 | Clinical Deep Phenotyping of <i>ABCA7</i> Mutation Carriers. | Neurol Genet | 2022 |
| 33252078 | Plasma Biomarkers of Alzheimer's Disease in African Americans. | J Alzheimers Dis | 2021 |
| 34020725 | Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease. | Acta Neuropathol Commun | 2021 |
| 32928256 | Correction to: Deciphering cellular transcriptional alterations in Alzheimer's disease brains. | Mol Neurodegener | 2020 |
| 33092647 | Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy. | Acta Neuropathol Commun | 2020 |
| 32660529 | Deciphering cellular transcriptional alterations in Alzheimer's disease brains. | Mol Neurodegener | 2020 |
| 29107053 | Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases. | Alzheimers Dement | 2018 |
| 30136084 | Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. | Acta Neuropathol | 2018 |
| 30326945 | ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. | Mol Neurodegener | 2018 |
| 27939925 | A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression. | Alzheimers Dement | 2017 |
| 28097223 | <i>ABCA7</i> loss-of-function variants, expression, and neurologic disease risk. | Neurol Genet | 2017 |
| 27115769 | Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. | Acta Neuropathol | 2016 |
| 27727239 | Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases. | Sci Data | 2016 |
| 25189118 | Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease. | Neurobiol Aging | 2015 |
| 27066552 | Late-onset Alzheimer disease risk variants mark brain regulatory loci. | Neurol Genet | 2015 |
| 23643458 | Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects. | Alzheimers Dement | 2014 |
| 25324900 | Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. | Alzheimers Res Ther | 2014 |
| 23750206 | LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD). | PLoS One | 2013 |
| 22494505 | Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. | Mol Neurodegener | 2012 |
| 22722634 | Novel late-onset Alzheimer disease loci variants associate with brain gene expression. | Neurology | 2012 |
| 22685416 | Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. | PLoS Genet | 2012 |
| 21868378 | Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region. | J Biol Chem | 2011 |